Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana W Shineman

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Dialogues in Clinical Neuroscience|July 10, 2009
Novel strategies for the prevention of dementia from Alzheimer's diseaseDiana W Shineman, Howard M Fillit
BMC Neurology|June 19, 2009
Meeting the unique challenges of drug discovery for neurodegenerative diseasesDiana W Shineman, Howard M Fillit
Alzheimer'S Research & Therapy|January 13, 2012
Beyond amyloid: a diverse portfolio of novel drug discovery programs for Alzheimer's disease and related dementiasRachel F Lane, Diana W Shineman, Howard M Fillit
Alzheimer'S Research & Therapy|December 17, 2010
A diverse portfolio of novel drug discovery efforts for Alzheimer's disease: Meeting report from the 11th International Conference on Alzheimer's Drug Discovery, 27-28 September 2010, Jersey City, NJ, USALinda H Lee, Diana W Shineman, Howard M Fillit
Alzheimer'S Research & Therapy|February 5, 2013
Diverse therapeutic targets and biomarkers for Alzheimer's disease and related dementias: report on the Alzheimer's Drug Discovery Foundation 2012 International Conference on Alzheimer's Drug DiscoveryRachel F Lane, Penny A Dacks, Diana W Shineman, et al.
Biochemistry|February 25, 2009
Constitutively active Akt inhibits trafficking of amyloid precursor protein and amyloid precursor protein metabolites through feedback inhibition of phosphoinositide 3-kinaseDiana W Shineman, Aleksandra S Dain, Minkyu L Kim, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 2, 2008
Thromboxane receptor activation mediates isoprostane-induced increases in amyloid pathology in Tg2576 miceDiana W Shineman, Bin Zhang, Susan N Leight, et al.
Alzheimer'S Research & Therapy|October 3, 2013
Progress in novel cognitive enhancers for cognitive aging and Alzheimer's diseaseDiana W Shineman, Aaron J Carman, Penny A Dacks, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 1, 2011
An analysis of global research funding for the frontotemporal dementias: 1998-2008Christopher D Walentas, Diana W Shineman, Antony R Horton, et al.
Advances in Pharmacology (San Diego, Calif.)|July 31, 2012
Beyond amyloid: the future of therapeutics for Alzheimer's diseaseRachel F Lane, Diana W Shineman, John W Steele, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Dialogues in Clinical Neuroscience|July 10, 2009
Novel strategies for the prevention of dementia from Alzheimer's diseaseDiana W Shineman, Howard M Fillit
BMC Neurology|June 19, 2009
Meeting the unique challenges of drug discovery for neurodegenerative diseasesDiana W Shineman, Howard M Fillit
Alzheimer'S Research & Therapy|January 13, 2012
Beyond amyloid: a diverse portfolio of novel drug discovery programs for Alzheimer's disease and related dementiasRachel F Lane, Diana W Shineman, Howard M Fillit
Alzheimer'S Research & Therapy|December 17, 2010
A diverse portfolio of novel drug discovery efforts for Alzheimer's disease: Meeting report from the 11th International Conference on Alzheimer's Drug Discovery, 27-28 September 2010, Jersey City, NJ, USALinda H Lee, Diana W Shineman, Howard M Fillit
Alzheimer'S Research & Therapy|February 5, 2013
Diverse therapeutic targets and biomarkers for Alzheimer's disease and related dementias: report on the Alzheimer's Drug Discovery Foundation 2012 International Conference on Alzheimer's Drug DiscoveryRachel F Lane, Penny A Dacks, Diana W Shineman, et al.
Biochemistry|February 25, 2009
Constitutively active Akt inhibits trafficking of amyloid precursor protein and amyloid precursor protein metabolites through feedback inhibition of phosphoinositide 3-kinaseDiana W Shineman, Aleksandra S Dain, Minkyu L Kim, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 2, 2008
Thromboxane receptor activation mediates isoprostane-induced increases in amyloid pathology in Tg2576 miceDiana W Shineman, Bin Zhang, Susan N Leight, et al.
Alzheimer'S Research & Therapy|October 3, 2013
Progress in novel cognitive enhancers for cognitive aging and Alzheimer's diseaseDiana W Shineman, Aaron J Carman, Penny A Dacks, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 1, 2011
An analysis of global research funding for the frontotemporal dementias: 1998-2008Christopher D Walentas, Diana W Shineman, Antony R Horton, et al.
Advances in Pharmacology (San Diego, Calif.)|July 31, 2012
Beyond amyloid: the future of therapeutics for Alzheimer's diseaseRachel F Lane, Diana W Shineman, John W Steele, et al.
Pageof 2